These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3083041)

  • 1. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
    Svensson K; Hjorth S; Clark D; Carlsson A; Wikström H; Andersson B; Sanchez D; Johansson AM; Arvidsson LE; Hacksell U
    J Neural Transm; 1986; 65(1):1-27. PubMed ID: 3083041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K; Johansson AM; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
    J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.
    Piercey MF; Lum JT
    Eur J Pharmacol; 1990 Jul; 182(2):219-26. PubMed ID: 2397740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats.
    Svensson K; Carlsson M; Carlsson A; Hjorth S; Johansson AM; Eriksson E
    Eur J Pharmacol; 1986 Nov; 130(3):237-42. PubMed ID: 3792447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion.
    Hajos M; Hjorth S; Svensson K; Carlsson A
    Exp Brain Res; 1988; 70(3):577-84. PubMed ID: 3133239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors.
    Svensson K; Carlsson A; Johansson AM; Arvidsson LE; Nilsson JL
    J Neural Transm; 1986; 65(1):29-38. PubMed ID: 3958706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
    Johansson AM; Fredriksson K; Hacksell U; Grol CJ; Svensson K; Carlsson A; Sundell S
    J Med Chem; 1990 Oct; 33(10):2925-9. PubMed ID: 2120444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L; Höök BB; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U; Johansson AM; Arvidsson L; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Sanchez D; Lindberg P
    J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat.
    Svensson K; Alföldi P; Hajós M; Rubicsek G; Johansson AM; Carlsson A; Obál F
    Pharmacol Biochem Behav; 1987 Jan; 26(1):123-9. PubMed ID: 3562484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
    J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.
    Vermue NA; Kaptein B; Tepper PG; de Vries JB; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():37-56. PubMed ID: 3421784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L; Mellin C; Hacksell U; Andén NE
    Eur J Pharmacol; 1987 Nov; 143(1):55-63. PubMed ID: 2961582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
    Hillver SE; Björk L; Li YL; Svensson B; Ross S; Andén NE; Hacksell U
    J Med Chem; 1990 Jun; 33(6):1541-4. PubMed ID: 2140413
    [No Abstract]   [Full Text] [Related]  

  • 20. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
    Johansson AM; Nilsson JL; Karlén A; Hacksell U; Sanchez D; Svensson K; Hjorth S; Carlsson A; Sundell S; Kenne L
    J Med Chem; 1987 Oct; 30(10):1827-37. PubMed ID: 3656358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.